Abivax SA American Depositary Shares (ABVX) is a publicly traded Healthcare sector company. As of May 21, 2026, ABVX trades at $121.17 with a market cap of $9.00B and a P/E ratio of 0.00. ABVX moved +5.32% today. Year to date, ABVX is -2.70%; over the trailing twelve months it is +1967.24%. Its 52-week range spans $4.77 to $148.83. Analyst consensus is strong buy with an average price target of $152.25. Rallies surfaces ABVX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Abivax SA American Depositary Shares (ABVX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ABVX moved +5.32% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $121.17 |
| Market Cap | $9.00B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $148.83 |
| 52-Week Low | $4.77 |
| Volume | 2.49K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
8 analysts cover ABVX: 0 strong buy, 7 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $152.25.